Erkrankungen der Leber

• Literatur

• 1 Cornberg M, Protzer U, Petersen J et al. Aktualisierung der S3-Leitlinie zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion. Z Gastroenterol 2011; 49: 871-930
• 2 Sarrazin C, Berg T, Buggisch P et al. Aktuelle Empfehlung zur Therapie der chronischen Hepatitis C. Z Gastroenterol 2015; 53: 320-334
• 3 Roeb E, Steffen HM, Bantel H et al. S2k-Leitlinie nicht alkoholische Fettlebererkrankungen. Z Gastroenterol 2015; 53: 668-723
• 4 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol 2015; 63: 971-1004
• 5 Beuers U, Gershwin ME, Gish RG et al. Changing nomenclature for PBC: From ‚cirrhosis‘ to ‚cholangitis‘. Hepatology 2015; 62: 1620-1622
• 6 Lindor KD, Gershwin ME, Poupon R et al. Primary biliary cirrhosis. Hepatology 2009; 50: 291-308
• 7 Lindor KD, Kowdley KV, Harrison ME et al. ACG Clinical Guideline: Primary Sclerosing Cholangitis. Am J Gastroenterol 2015; 110: 646-659
• 8 Bacon BR, Adams PC, Kowdley KV et al. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011; 54: 328-343
• 9 Muir AJ. Understanding the complexities of cirrhosis. Clin Ther 2015; 37: 1822-1836
• 10 Yu SJ. A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010–2016. Clin Mol Hepatol 2016; 22: 7-17
• 11 Bruix J, Sherman M et al. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022